Oruka Therapeutics, Inc (ORKA) insider trading
Every open-market stock purchase and sale by Oruka Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Lawrence Otto Klein (CEO) and 4 others sold $22M in the last 90 days.
- Last insider buy: Venrock Healthcare Capital Partners III L.P. (Insider), $1M, 20 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $338M (42 sales). Last close $81.15 on Oct 22, 2026.
Recent ORKA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 20, 2026 | Paul T Quinlan (General Counsel) | Sold | $323K |
| Oct 20, 2026 | Paul T Quinlan (General Counsel) | Sold | $238K |
| Oct 20, 2026 | Paul T Quinlan (General Counsel) | Sold | $77.2K |
| Oct 20, 2026 | Paul T Quinlan (General Counsel) | Bought (not open market) | $70.2K |
| Oct 20, 2026 | Paul T Quinlan (General Counsel) | Sold | $38.1K |
| Oct 20, 2026 | Paul T Quinlan (General Counsel) | Sold | $30K |
| Oct 20, 2026 | Paul T Quinlan (General Counsel) | Bought (not open market) | — |
| Oct 15, 2026 | Joana Goncalves (C-suite exec) | Sold | $211K |
| Oct 15, 2026 | Joana Goncalves (C-suite exec) | Sold | $138K |
| Oct 15, 2026 | Joana Goncalves (C-suite exec) | Sold | $106K |
| Oct 15, 2026 | Joana Goncalves (C-suite exec) | Sold | $53.7K |
| Oct 15, 2026 | Joana Goncalves (C-suite exec) | Bought (not open market) | $27.3K |
| Oct 15, 2026 | Joana Goncalves (C-suite exec) | Bought (not open market) | $23.9K |
| Oct 15, 2026 | Joana Goncalves (C-suite exec) | Sold | $15.5K |
| Oct 15, 2026 | Joana Goncalves (C-suite exec) | Bought (not open market) | — |
| Oct 15, 2026 | Joana Goncalves (C-suite exec) | Bought (not open market) | — |
| Oct 12, 2026 | Arjun Agarwal (President) | Sold | $459K |
| Oct 12, 2026 | Arjun Agarwal (President) | Sold | $170K |
| Oct 12, 2026 | Arjun Agarwal (President) | Sold | $160K |
| Oct 12, 2026 | Arjun Agarwal (President) | Bought (not open market) | $107K |
| Oct 12, 2026 | Arjun Agarwal (President) | Bought (not open market) | $50.1K |
| Oct 12, 2026 | Arjun Agarwal (President) | Sold | $16.6K |
| Oct 12, 2026 | Arjun Agarwal (President) | Bought (not open market) | — |
| Oct 12, 2026 | Arjun Agarwal (President) | Bought (not open market) | — |
| Oct 1, 2026 | Lawrence Otto Klein (CEO) | Sold | $1.4M |
Who's trading ORKA
- Paul T Quinlan, General Counsel: sold $7.5M (18 sales), last Oct 20, 2026
- Joana Goncalves, C-suite exec: sold $5.1M (40 sales), last Oct 15, 2026
- Arjun Agarwal, President: sold $5.1M (29 sales), last Oct 12, 2026
- Lawrence Otto Klein, CEO: sold $9.4M (9 sales), last Oct 1, 2026
- Laura Lee Sandler, COO: sold $1.9M (19 sales), last Sep 15, 2026
- Larry Todd Edwards, C-suite exec: other filings, last Aug 24, 2026
- Fairmount Funds Management LLC, 10% owner: sold $300M (1 sale), last Jul 1, 2026
- Carl Dambkowski, Director: sold $8.6M (5 sales), last Jun 12, 2026
- Christopher Nathan Martin, Director: other filings, last Jun 2, 2026
- Samarth Kulkarni, Director: other filings, last Jun 2, 2026
- Kristine M Ball, Director: other filings, last Jun 2, 2026
Get free alerts when an insider at Oruka Therapeutics, Inc files a new trade →